glp 1 agonist effects Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist GLP-1 Drugs & What They

Implications from the study included that 8.9% of diabetic patients and 6.7% of obese patients on GLP-1 developed NAION compared to 1.8% and 0.8% respectively in those using other medications

It's important to note that endogenous GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4), giving it a very short half-life in circulation

Investigation of the Haemodynamic Effects of Exenatide in Healthy Male Subjects

GLP-1 Analog Liraglutide Protects Against Cardiac Steatosis, Oxidative Stress and Apoptosis in Streptozotocin-Induced Diabetic Rats

That is especially important for active adults and anyone trying to preserve muscle while losing weight